Cipla has chosen Mawdsleys as their UK distributor to hospitals.

Cipla selects Mawdsleys as their UK distributor to hospitals

Cipla selects Mawdsleys as their UK distributor to hospitals 29th May 2020

Mawdsleys is delighted to be partnering with Cipla to distribute their contract and non contract products to hospitals from 1st June 2020.

Cameron McMaster, Associate Director UK Sales at Cipla says “We have chosen Mawdsleys to take full charge of our Hospital distribution due to their experience and reputation within this sector. We look forward to a long and prosperous relationship ensuring healthcare needs are met within this arena.”

The products will be listed on Mawdsleys Online and available to order for customers from 1^st June 2020.

Other latest news

Our portfolio is expanding

As from 1st June we are distributing products to hospitals on behalf of Hikma Pharmaceuticals, adding to our growing portfolio of products and manufacturers. If you are a manufacturer or hospital and want to know more about how Mawdsleys can support and work with you, contact us today…

Mawdsleys and Oncoscience launch a Named Patient Program for CIMAher®

Mawdsleys and Oncoscience GMbH have launched a Named Patient Supply Program to allow Oncologists in the United Kingdom (UK) and Ireland to obtain access to CIMAher® (Nimotuzumab) on an unlicensed basis for the treatment of various types of cancer. Nimotuzumab has been approved for marketing in 25 different countries worldwide for a variety of…